TrialCancer communications (London, England)2020

Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first-line treatment of advanced esophageal squamous cell carcinoma.

Bo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.